Literature DB >> 3435700

Immunophenotype of the lymphoid cell infiltrates in breast carcinomas of low oestrogen receptor content.

J C Underwood1, D D Giri, N Rooney, R Lonsdale.   

Abstract

Several studies of breast tumour histology and oestrogen receptor (ER) contents report an inverse correlation between the density of the stromal lymphoid cell infiltrate and the presence or concentration of ER. Using monoclonal antibodies to lymphoid cell surface markers we have examined the immunophenotype of the infiltrating lymphoid cells and related this to the tumour ER content. There is a significant inverse correlation between the presence of Leu7-positive cells, which includes a subpopulation of natural killer (NK) cells, and tumour ER content; this is possibly superimposed on the dilutional effect of macrophages and other infiltrating cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3435700      PMCID: PMC2002391          DOI: 10.1038/bjc.1987.281

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  Lymphoreticular infiltrates in invasive ductal breast cancer. A histological and immunohistological study.

Authors:  H P Horny; H A Horst
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Immunoglobulin G (IgG) levels in breast tumor cytosols.

Authors:  S Winsten; J Tabachnick; I Young
Journal:  Am J Clin Pathol       Date:  1985-03       Impact factor: 2.493

3.  Immunohistology of oestrogen receptor and D5 antigen in breast cancer: correlation with oestrogen receptor content of adjacent cryostat sections assayed by radioligand binding and enzyme immunoassay.

Authors:  D D Giri; V J Dangerfield; R Lonsdale; K Rogers; J C Underwood
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

4.  Monoclonal antibodies to human estrogen receptor.

Authors:  G L Greene; C Nolan; J P Engler; E V Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

5.  Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.

Authors:  L L Lanier; A M Le; J H Phillips; N L Warner; G F Babcock
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

6.  Oestrogen receptor assay of cryostat sections of human breast carcinomas with simultaneous quantitative histology.

Authors:  J C Underwood; V J Dangerfield; M A Parsons
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

7.  Oestrogen receptor concentration and macrophage infiltration in human breast cancer.

Authors:  R J Steele; O Eremin; M Brown; R A Hawkins
Journal:  Eur J Surg Oncol       Date:  1986-09       Impact factor: 4.424

8.  Characterisation of macrophages infiltrating human mammary carcinomas.

Authors:  R J Steele; M Brown; O Eremin
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

Review 9.  Lymphoreticular infiltration in human tumours: prognostic and biological implications: a review.

Authors:  J C Underwood
Journal:  Br J Cancer       Date:  1974-12       Impact factor: 7.640

10.  Histology in breast cancer prognosis.

Authors:  H R Champion; I W Wallace; R J Prescott
Journal:  Br J Cancer       Date:  1972-04       Impact factor: 7.640

  10 in total
  3 in total

1.  Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival.

Authors:  H O Wintzer; W Bohle; S von Kleist
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

Review 2.  Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Authors:  R Clarke
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer.

Authors:  P Whitford; E A Mallon; W D George; A M Campbell
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.